RVPHW

Reviva Pharmaceuticals Holdings, Inc.

Healthcare · USD

Set alert

Price alert · RVPHW

All alert types
0.00 USD 0.00 -16.67%
As of Dec 12, 2025 Extended hours 0.00 -70.00%
Bid
— × —
Ask
0.01 × —
0.003 Day range 0.0046
0.003 52-week range 0.0046
YTD
0.00%
1 year
0.00%
Open
0.041
Prev close
0.0036
Mkt cap
343.91K
Vol
303.38K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.003
High
0.0046
Forward P/E
0.00
Beta
-0.06
Short ratio
0.00
Inst. own
0.00%
Dividend
0.00
Ex-div date
50-d avg
0.00
200-d avg
0.00
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for RVPHW has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-15.27 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.0×
FY 2018: -12.2×FY 2019: -34.1×FY 2020: -7.0×FY 2021: -5.0×FY 2022: -2.9×FY 2023: -3.1×FY 2024: -2.0×FY 2025: -1.0×
FY 2018 5y median -2.9× FY 2025
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 2.3×
FY 2018: 0.0×FY 2019: -4.3×FY 2020: 4.9×FY 2021: 1.5×FY 2022: 9.9×FY 2023: 21.4×FY 2024: 73.8×FY 2025: 2.3×
FY 2018 5y median 9.9× FY 2025
P/FCF -0.8×
FY 2018: -19.2×FY 2019: -134×FY 2020: -6.6×FY 2021: -4.0×FY 2022: -4.4×FY 2023: -4.3×FY 2024: -1.8×FY 2025: -0.8×
FY 2018 5y median -4.0× FY 2025
EV/EBITDA -0.3×
FY 2018: -18.6×FY 2019: -87.8×FY 2020: -7.4×FY 2021: -1.3×FY 2022: 16.4×FY 2023: 382×FY 2024: 51.2×FY 2025: -0.3×
FY 2018 5y median 16.4× FY 2025
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -121.5%
FY 2018: -5.2%FY 2019: -0.7%FY 2020: -15.2%FY 2021: -25.0%FY 2022: -22.9%FY 2023: -23.1%FY 2024: -55.9%FY 2025: -121.5%
FY 2018 5y median -25.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -229.7%
FY 2018: 0.0%FY 2019: 12.4%FY 2020: -69.2%FY 2021: -29.7%FY 2022: -290.0%FY 2023: -686.5%FY 2024: -3682.0%FY 2025: -229.7%
FY 2018 5y median -290.0% FY 2025
ROIC -223.1%
FY 2018: -1.7%FY 2019: -10.3%FY 2020: -32.8%FY 2021: -32.8%FY 2022: -5.9%FY 2023: -605.4%FY 2024: -2265.1%FY 2025: -223.1%
FY 2018 5y median -223.1% FY 2025
ROA -124.8%
FY 2018: -2.6%FY 2019: -32570.5%FY 2020: -43.2%FY 2021: -27.1%FY 2022: -128.6%FY 2023: -165.7%FY 2024: -193.0%FY 2025: -124.8%
FY 2018 5y median -128.6% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 FY 2025
Operating Income 34.4%
FY 2018: 0.0%FY 2019: 66.4%FY 2020: -546.0%FY 2021: -315.0%FY 2022: -140.6%FY 2023: -62.5%FY 2024: 22.0%FY 2025: 34.4%
FY 2018 FY 2025
EPS (diluted) 69.6%
FY 2018: 0.0%FY 2019: 62.4%FY 2020: -300.0%FY 2021: 53.2%FY 2022: -150.0%FY 2023: -13.8%FY 2024: 45.5%FY 2025: 69.6%
FY 2018 FY 2025
Free Cash Flow 26.7%
FY 2018: 0.0%FY 2019: 79.6%FY 2020: -1761.6%FY 2021: -162.3%FY 2022: -77.7%FY 2023: -49.4%FY 2024: -18.4%FY 2025: 26.7%
FY 2018 FY 2025

Financial Health

Current Ratio 2.1×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 6.6×FY 2021: 13.4×FY 2022: 1.9×FY 2023: 1.4×FY 2024: 1.0×FY 2025: 2.1×
FY 2018 5y median 1.9× FY 2025
Quick Ratio 2.1×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 6.6×FY 2021: 13.4×FY 2022: 1.9×FY 2023: 1.4×FY 2024: 1.0×FY 2025: 2.1×
FY 2018 5y median 1.9× FY 2025
Debt / Equity 0.0×
FY 2018: 0.0×FY 2019: -0.6×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.6×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2018: 0.0×FY 2019: -10.0×FY 2020: 3.6×FY 2021: 2.9×FY 2022: -4.7×FY 2023: -90.0×FY 2024: -14.2×FY 2025: 0.7×
FY 2018 5y median -4.7× FY 2025
Interest Coverage -1507×
FY 2018: -2.0×FY 2019: -0.8×FY 2020: -1.7×FY 2021: -4186×FY 2022: -133×FY 2023: -1171×FY 2024: -1665×FY 2025: -1507×
FY 2018 5y median -1507× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31